COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 87 filers reported holding COHERUS BIOSCIENCES INC in Q2 2016. The put-call ratio across all filers is 2.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $12 | – | 6,000 | +46.3% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 4,100 | -6.8% | 0.00% | – |
Q4 2019 | $6,000 | -81.2% | 4,400 | +175.0% | 0.00% | -100.0% |
Q3 2019 | $32,000 | – | 1,600 | +60.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 1,000 | -44.4% | 0.00% | -100.0% |
Q3 2018 | $29,000 | +2800.0% | 1,800 | -64.0% | 0.00% | – |
Q2 2018 | $1,000 | -98.6% | 5,000 | -25.4% | 0.00% | -100.0% |
Q1 2018 | $74,000 | +1.4% | 6,700 | -25.6% | 0.01% | +100.0% |
Q4 2017 | $73,000 | -71.0% | 9,004 | -67.2% | 0.00% | -70.0% |
Q3 2017 | $252,000 | -4.5% | 27,472 | -28.2% | 0.01% | 0.0% |
Q2 2017 | $264,000 | +149.1% | 38,284 | +134.9% | 0.01% | +100.0% |
Q1 2017 | $106,000 | -60.6% | 16,300 | -63.5% | 0.01% | -50.0% |
Q4 2016 | $269,000 | +12.1% | 44,621 | -14.1% | 0.01% | -9.1% |
Q3 2016 | $240,000 | +1900.0% | 51,920 | +253.2% | 0.01% | – |
Q2 2016 | $12,000 | +9.1% | 14,700 | +34.9% | 0.00% | -100.0% |
Q1 2016 | $11,000 | – | 10,900 | +581.2% | 0.00% | – |
Q4 2015 | $0 | – | 1,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |